What is the primary business of McKesson Corporation?

Based on the context of a healthcare-related SEC filing, McKesson Corporation is a major player in the healthcare industry, primarily involved in the distribution of pharmaceuticals and healthcare products, and the provision of healthcare information technology services.

Where can I find the detailed financial results for this period?

The provided text is a directory listing from the SEC's EDGAR database. To find the detailed financial results, you would need to access the actual financial statements and management's discussion and analysis (MD&A) within the full 10-Q filing, typically linked from the directory or available via the company's investor relations website.

What are the key risks or opportunities for McKesson at the time of this filing?

Without the full financial statements and MD&A, specific risks and opportunities cannot be detailed. However, generally for a company like McKesson in 1999/2000, key factors would include regulatory changes in healthcare and drug pricing, competition in pharmaceutical distribution, the integration of technology solutions, and potential mergers and acquisitions within the rapidly consolidating healthcare sector.

MCK 10-Q Quarterly Report Q3 FY2000 — Revenue, Net Income, EPS

Summary

McKesson Corporation's 10-Q filing for the period ending December 30, 1999, reveals a company operating in a dynamic healthcare distribution and information technology sector. While the provided filing content is primarily navigational and does not contain detailed financial statements or management discussion, it indicates McKesson is actively participating in the public markets and subject to regulatory oversight. Investors should focus on the company's strategic positioning within the healthcare supply chain and its investments in technology solutions, which are key drivers of growth in this industry.

Key Highlights

1The filing is for McKesson Corporation (MCK) for the period ending December 30, 1999, filed on February 13, 2000.
2This report is a 10-Q, indicating it's a quarterly financial filing with the SEC.
3The filing originates from the SEC's EDGAR database, suggesting it's a publicly available document.
4The available content is a directory listing, not the full financial report, implying the actual financial details are in linked documents.
5McKesson operates within the healthcare industry, likely involving pharmaceuticals and related services.
6The date of the filing places it at a critical time for many companies, as they report on performance leading into the new millennium.

MCKESSON CORP Quarterly Report for Q3 Ended Dec 31, 1999

Summary

Key Highlights

Frequently Asked Questions